Utah Medical Products (UTMD) Other Accumulated Expenses (2012 - 2025)

Utah Medical Products' Other Accumulated Expenses history runs 14 years deep, the most recent figure standing at $1.7 million for Q4 2025.

• On a quarterly basis, Other Accumulated Expenses fell 14.32% year-over-year to $1.7 million in Q4 2025; TTM through Dec 2025 was $1.7 million, a 14.32% decrease from a year earlier, with the FY2025 full-year figure at $1.7 million, down 14.32% from the prior year.
• Other Accumulated Expenses retreated to $1.7 million in Q4 2025 per UTMD's latest filing, from $2.0 million in the prior quarter.
• Across five years, Other Accumulated Expenses topped out at $2.9 million in Q4 2022 and bottomed at $1.6 million in Q4 2021.
• The 5-year median for Other Accumulated Expenses is $2.0 million (2024), against an average of $2.0 million.
• Across the five-year window, Other Accumulated Expenses surged 77.2% in 2022 and declined 28.44% in 2023, its largest moves.
• Year by year, Other Accumulated Expenses stood at $1.6 million in 2021, then soared by 77.2% to $2.9 million in 2022, then retreated by 28.44% to $2.1 million in 2023, then dropped by 5.24% to $2.0 million in 2024, then fell by 14.32% to $1.7 million in 2025.
• Per Business Quant, the three latest UTMD Other Accumulated Expenses figures stand at $1.7 million (Q4 2025), $2.0 million (Q4 2024), and $2.1 million (Q4 2023).